Edge Therapeutics, Inc. (EDGE) Reaches $13.97 After 8.00% Up Move; TOWERSTREAM CORPORATION (TWER) SI Increased By 7.93%

February 15, 2018 - By Peter Erickson

The stock of Edge Therapeutics, Inc. (NASDAQ:EDGE) is a huge mover today! The stock increased 1.56% or $0.215 during the last trading session, reaching $13.965. About 74,204 shares traded. Edge Therapeutics, Inc. (NASDAQ:EDGE) has risen 23.72% since February 15, 2017 and is uptrending. It has outperformed by 7.02% the S&P500.The move comes after 7 months positive chart setup for the $430.95M company. It was reported on Feb, 15 by Barchart.com. We have $15.08 PT which if reached, will make NASDAQ:EDGE worth $34.48 million more.

TOWERSTREAM CORPORATION (OTCMKTS:TWER) had an increase of 7.93% in short interest. TWER’s SI was 24,500 shares in February as released by FINRA. Its up 7.93% from 22,700 shares previously. With 5,500 avg volume, 5 days are for TOWERSTREAM CORPORATION (OTCMKTS:TWER)’s short sellers to cover TWER’s short positions. The stock increased 7.14% or $0.19 during the last trading session, reaching $2.85. About 385 shares traded. Towerstream Corporation (OTCMKTS:TWER) has 0.00% since February 15, 2017 and is . It has underperformed by 16.70% the S&P500.




Towerstream Corporation, together with its subsidiaries, provides fixed wireless broadband services over a wireless network transmitting over regulated and unregulated radio spectrum to commercial clients in the United States. The company has market cap of $1.12 million. The companyÂ’s wireless broadband service supports bandwidth on demand, wireless redundancy, virtual private networks, disaster recovery, bundled data, and video services. It currently has negative earnings. It serves business clients in New York City, Boston, Chicago, Los Angeles, San Francisco, Seattle, Miami, Dallas-Fort Worth, Houston, Philadelphia, Las Vegas-Reno, and Providence-Newport.

Analysts await Edge Therapeutics, Inc. (NASDAQ:EDGE) to report earnings on March, 1. They expect $-0.47 earnings per share, down 42.42% or $0.14 from last year’s $-0.33 per share. After $-0.37 actual earnings per share reported by Edge Therapeutics, Inc. for the previous quarter, Wall Street now forecasts 27.03% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: